Preclinical study of the long‐range safety and anti‐inflammatory effects of high‐dose oral meglumine
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.28492
Abstract: Meglumine is a methylamino derivative of sorbitol that is an approved drug excipient. Recent preclinical studies suggest that administration of high‐dose oral meglumine can exert beneficial medicinal effects to treat diabetes, obesity, and fatty liver… read more here.
Keywords: anti inflammatory; meglumine; high dose; dose oral ... See more keywords